Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 41-50 of 61
Item hits:
Issue DateTitleAuthor(s)
23-Jun-2021First-line treatment options for PD-L1-negative non-small cell lung cancer: a Bayesian network meta-analysisPeng, L; Liang, W-H; Mu, D-G; Xu, S; Hong, S-D, et al
31-Jul-2020A real-world disproportionality analysis of FDA Adverse Event Reporting System (FAERS) events for baricitinib.Peng, L; Xiao, K; Ottaviani, S; Stebbing, J; Wang, Y-J, et al
15-Apr-2020Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patientsStebbing, J; Krishnan, V; Bono, SD; Ottaviani, S; Casalini, G, et al
1-Jul-2017CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trialStebbing, J; Baranau, Y; Baryash, V; Manikhas, A; Moiseyenko, V, et al
1-Jun-2020PIK3Cδ expression by fibroblasts promotes triple-negative breast cancer progressionGagliano, T; Shah, K; Gargani, S; Lao, L; Alsaleem, M, et al
10-Dec-2020805 Safety and emerging evidence of immune modulation of the live biotherapeutic MRx0518 in the neoadjuvant setting for patients awaiting surgical removal of solid tumoursLythgoe, M; Stebbing, J; Pickford, E; Glasmacher, A; Adriani, M, et al
7-Aug-2020Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patientsStebbing, J; Krishnan, V; De Bono, S; Ottaviani, S; Casalini, G, et al
Mar-2022Immunogenicity after six months of BNT162b2 vaccination in frail or disabled nursing home residents: the COVID-A StudyRíos, SS; Zamora, EBC; Céspedes, AA; Rizos, LR; Sánchez-Jurado, PM, et al
29-Jul-2021JAK inhibitors — More than just glucocorticoidsStebbing, J; Lauschke, VM;
15-Jan-2021COVID-19 and the risk to cancer patients in China.Williams, J; Stebbing, J;